Subcutaneous erythropoietin results in lower dose and equivalent hematocrit levels among adult hemodialysis patients: Results from the 1998 End-Stage Renal Disease Core Indicators Project

Abstract
No abstract available

This publication has 0 references indexed in Scilit: